I can understand why investors would be excited by the possibility of better results at Emerson (EMR). Although this industrial conglomerate has been a middle-of-the-pack performer, the company's high exposure to emerging markets (and China in particular) makes it a good name to turn to when looking for growth or recovery prospects. That said, this quarter shows that Emerson is still Emerson and for every step forward, there seems to always be at least a little simultaneous scoot backwards.
Not A Bad Start To Fiscal 2013
Emerson reported results for the fiscal first quarter that weren't bad, but did have a few flaws to them.
Revenue rose about 5% as reported, with 6% underlying organic growth, which was...
Only subscribers can access this article, which is part of the PRO research library covering 3,775 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: